Natalizumab in Multiple Sclerosis: Long-Term Management

Natalizumab is a monoclonal antibody highly effective in the treatment of relapsing remitting multiple sclerosis (RRMS) patients. Despite its effectiveness, there are growing concerns regarding the risk of progressive multifocal leukoencephalopathy (PML), a brain infection caused by John Cunningham...

Full description

Saved in:
Bibliographic Details
Published in:Int J Mol Sci
Main Authors: Clerico, Marinella, Artusi, Carlo Alberto, Di Liberto, Alessandra, Rolla, Simona, Bardina, Valentina, Barbero, Pierangelo, De Mercanti, Stefania Federica, Durelli, Luca
Format: Artigo
Language:Inglês
Published: MDPI 2017
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5454853/
https://ncbi.nlm.nih.gov/pubmed/28468254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18050940
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items